PCI Biotech Holding ASA (OSL: PCIB)
1.850
+0.050 (2.78%)
Aug 30, 2024, 4:25 PM CET
PCI Biotech Holding ASA Revenue
PCI Biotech Holding ASA had revenue of 1.71M NOK in the quarter ending June 30, 2024, with 825.95% growth. This brings the company's revenue in the last twelve months to 6.00M, up 114.86% year-over-year. In the year 2023, PCI Biotech Holding ASA had annual revenue of 2.99M, down -37.05%.
Revenue (ttm)
6.00M
Revenue Growth
+114.86%
P/S Ratio
n/a
Revenue / Employee
999.83K
Employees
6
Market Cap
69.05M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.99M | -1.76M | -37.05% |
Dec 31, 2022 | 4.75M | -1.52M | -24.28% |
Dec 31, 2021 | 6.27M | -1.10M | -14.86% |
Dec 31, 2020 | 7.37M | -2.02M | -21.55% |
Dec 31, 2019 | 9.39M | -193.00K | -2.01% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |